Perspective Archives - Page 2 of 4 - Inbeeo Strategic Market Access & Pricing

Home
What we do

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

What we do

Define your value strategy

We offer best-in-class strategy development tailored to your objectives to help realize the full value of your products and technologies.

Optimize your evidence plan

We can help you collect and understand complex data about your asset, indications, and the pricing and access environment, then turn them into simple overviews and strategic insights with impact.

Price your asset right

Our pricing solutions help you achieve a price for your health technology which reflects its true value to patients, different healthcare systems and society as a whole.

Communicate the value

We work with you to gather the evidence, formulate the insights, and create the arguments you need to explain the value of your technology to payers and other key healthcare stakeholders.

Navigate access policies

We help our customers align their internal priorities with external health policy developments to bolster overall success.
Who we are

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Who we are

Our Team

Our team represents a unique combination of expertise gained at leading pharmaceutical companies, leading consultancies, and leading universities.
Our Products

Get in touch

Realize the true value of your healthcare assets.
Get started with Inbeeo today.

Contact us

Our Products

i•vbp

Easy-to-use and secure cloud-based application that enables the generation of custom value frameworks tailored to demonstrate the full value of your assets.

i•pec

We have a strong network of international payers and experts with decades of experience in HTA, P&R and HEOR in their local markets.

i•las

Bringing together global market access leaders for collaborative discussions on industry-wide topics and challenges.
Our Insights

Latest Article

Biosimilar Pricing and Competition: How Political Visibility Shapes Biologic Pricing After Loss of Exclusivity

Introduction Biologics have reshaped the treatment landscape across a broad

Read More »

Our Insights

Perspectives

A deep dive into the world of Market Access. Discover our perspectives on the latest developments in our field.

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

News

Find out what’s going on with Inbeeo, where we’ve been and who we’ve been talking to.
Join our team

Project Cases

Discover how we have helped some of our great clients and how we may be able to help you too.

US - EU Price Differences

Navigate access policies

How IRA Negotiations Are Shaping US-EU Drug Price Differentials

Navigate access policies

The Impact of Access Policies on Biosimilar Pricing in Five Major EU Markets

Price Your Asset Right

Review on the effectiveness of Japan’s FY2024 reform on NHI price listing

Price Your Asset Right

Global Pharmaceutical Pricing and ESG: What Pharmaceutical Companies Can Learn From Marie Stella Maris

Former Heineken Brewery In Amsterdam

Define Your Value Strategy

Cheers To Driving Global Access: 3 Lessons Pharma Can Learn From Heineken

Price Your Asset Right

Exploring Net Price Dynamics of Orphan Drugs: EU4 and US Market Insights

Price Your Asset Right

Navigating Multi-Indication Pricing in Germany and France

Pricing dynamics of 10 digital health apps in Germany

Price Your Asset Right

Pricing of Digital Health Apps in Germany

Navigate access policies

Market Access: The Overlooked Dimension in ESG Reporting

Navigate access policies

Will AI-powered bots replace Market Access professionals?